Cargando…
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction
Diabetes is the leading cause of chronic kidney disease, and even in the absence of albuminuria, decreased renal function in type 2 diabetes mellitus (T2DM) patients increases the risk for major adverse cardiovascular events and death. The evidence derived from recent studies suggests that intensive...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688978/ https://www.ncbi.nlm.nih.gov/pubmed/28983844 http://dx.doi.org/10.1007/s13300-017-0302-3 |